MedPath

The Application of Music Therapy in Female Amphetamine Use Disorder

Not Applicable
Completed
Conditions
Amphetamine Addiction
Interventions
Behavioral: Music therapy group
Registration Number
NCT03221283
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

The group music therapy will be used to treat female amphetamine-type stimulant (ATS) addiction

Detailed Description

Amphetamine addicts are often accompanied by severe emotional problems and are difficult to control and regulate negative emotions by themselves.And the emotional problems are high risk factors of addicts relapse. Music therapy as the intervention is in order to improve amphetamine addicts' emotional status and the ability of emotion regulation. Self-rating Depression Scale(SDS), Self-rating Anxiety scale(SAS) will be used to investigate the emotion of participants. These methods will also be used to evaluate the efficacy of the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorder
  • Junior high school degree or above
  • Normal vision and hearing
  • Have emotional problem
Exclusion Criteria
  • Other substance abuse or dependence in recent a years (except nicotine)
  • Mental impairment, Intelligence Quotient (IQ) < 70
  • Mental disorders
  • Physical disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Music therapy groupMusic therapy groupUse randomized controlled clinical trial design.The main content of music therapy is emotional experience , emotion regulation, emotional control and emotional expression. The experimental group received 13 group music sessions over a three-month period.
Primary Outcome Measures
NameTimeMethod
Change from Baseline Depression status assessed by Self-rating Depression Scale (SDS) at 4 months.Baseline, 2 months,4 months, and 7months

evaluate all participants' depression status by Self-rating Depression Scale (SDS)

Secondary Outcome Measures
NameTimeMethod
Change from Baseline Craving for ATS assessed by Visual Analog Scales (VAS)Baseline, 2 months,4 months, and 7months

evaluate all participants' craving for ATS by Visual Analog Scales (VAS)

Anxiety status assessed by Self-rating Anxiety Scale (SAS)Baseline, 2 months,4 months, and 7months

evaluate all participants' anxiety status by Self-rating Anxiety Scale (SAS)

Empathy ability assessed by Interpersonal Reactivity Index-C(IRI-C)Baseline, 2 months,4 months, and 7months

evaluate all participants' Empathy ability by Interpersonal Reactivity Index-C(IRI-C)

Motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES)Baseline, 2 months,4 months, and 7months

evaluate all participants' motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES)

Change from Baseline emotional status assessed by emotional STROOP paradigmBaseline, 2 months,4 months, and 7months

evaluate all participants' emotional status by emotional STROOP paradigm

Sleep status assessed by Pittsburgh Sleep Quality Index(PSQI)Baseline, 2 months,4 months, and 7months

evaluate all participants' sleep status by Pittsburgh Sleep Quality Index(PSQI)

Trial Locations

Locations (1)

Shanghai Women's Compulsory Isolation Detoxification Center

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath